Innovation and technological leadership for lubricants
The high level of innovative power is a key driving force in the FUCHS business model. FUCHS excels through its above industry-average speed of innovation and high degree of specialization. The objective is to continuously develop the potential of lubricants; that is, increasing efficiency as well as prolonging product lifecycles, developing multifunctional lubricants and innovative products for new technical and regulatory requirements, in addition to improving energy, process and cost efficiency. At the same time, we are committed to sustainable objectives and the aspiration to develop lubricant solutions that contribute to conservation of the environment and resources.
Great emphasis is therefore placed on research and development in the FUCHS Group. The company currently has more than 600 ongoing research and development projects that aim to evaluate the potential of new technologies such as nanotechnologies or minimum quantity lubrication. These projects are supported by around 400 engineers and scientists at 25 laboratory locations throughout the world. Approximately 10 % of the laboratory employees work in the field of research and development – and FUCHS continuously invests in the further expansion of its technical and personnel capacities. The ultra-modern Technology Center at the headquarters in Mannheim coordinates the international network of experts, brings together expertise and supports knowledge transfer on global requirements.
Research and development geared to the requirements of our customers
FUCHS engages in application-oriented development directly at and in cooperation with the customer with the aim of adapting lubricants optimally to the process and machine-related requirements. In addition to this, FUCHS attaches great importance to basic research and maintains commitments in interdisciplinary research projects and partnerships with universities, academic institutions, biotechnology companies and customers such as OEMs. FUCHS has extensive laboratory and simulation capacities. Product developments are accompanied by intensive series of tests. All lubricants used in the medical engineering sector are subjected to tests for cytotoxicity and any potential damage to cells and tissues. FUCHS is one of the few lubricant manufacturers that performs tests of this kind.
FUCHS SE and DMG MORI AKTIENGESELLSCHAFT strengthen their business relationship by signing a collaboration contract. DMG MORI is a leading producer worldwide of machine tools. In a technology partnership the companies intend to jointly develop new lubricant solutions and services for machine tool applications. The plan also includes further development in digitalization of production processes and condition monitoring of machines and plants. „DMG MORI has a high level of technological expertise, great innovative force and global presence. I am certain that customers and users, as well as the two companies, will benefit from this partnership“, says Stefan Fuchs, CEO of FUCHS SE.